Objective: Unplanned and poorly timed pregnancies are associated with adverse maternal and neonatal outcomes. Further understanding of preconception substance use with unplanned and poorly timed pregnancy is warranted. Methods: Data were analyzed from a prospective study enrolling women early in pregnancy. Preconception tobacco, alcohol, marijuana, opioid, and cocaine use was ascertained. Participants reported whether their current pregnancy was planned and whether it was a good time to be pregnant. Multivariable logistic regression modeling generated risk estimates for preconception substance use, and pregnancy planning and timing, adjusting for confounders. Results: Overall, 37.2% reported unplanned pregnancy, 13.0% poorly timed pregnancy, and 39.0% reported either unplanned and/or poorly timed pregnancy. Within 6 months preconception, one-fifth (20.2%) reported nicotine cigarette use. In the month before conception, 71.8% reported alcohol use, 6.5% marijuana, and approximately 1% opioid or cocaine use. Multivariable analysis demonstrated preconception opioid use was associated with increased odds of poorly timed pregnancy (odds ratio [OR] 2.87, 95% confidence interval [CI] 1.03-7.99). Binge drinking the month before conception was associated with increased odds of poorly timed pregnancy and unplanned pregnancy (OR 1.75, 95% CI 1.01-3.05; and OR 1.68, 95% CI 1.01-2.79, respectively). Marijuana use 2 to 3 times in the month preconception was associated with increased risk of unplanned pregnancy, and unplanned and/or poorly timed pregnancy compared with nonuse (OR 1.78, 95% CI 1.03-3.08; and OR 1.79, 95% CI 1.01-3.17, respectively). Preconception tobacco or cocaine use was not associated with unplanned or poorly timed pregnancy following adjustment. Conclusions: We demonstrate increased odds of unplanned or poorly timed pregnancy among women with preconception binge drinking, marijuana use, and opioid use; however, no association is observed with other substances after multivariable adjustment, including tobacco. Further research to evaluate high-level preconception substance use and substance disorders with pregnancy planning and timing is warranted. Focused efforts optimizing preconception health behaviors and reducing risk of unplanned or poorly timed pregnancy are needed.
pregnancy perspectives beyond unintended pregnancy, address preconception behaviors including substance use, and better understand the public health impact associated with these measures.
For women who are not planning or intending to become pregnant, some health behaviors and exposures that occur before conception may not be optimal for a pregnancy. Guidelines for optimizing preconception care include promotion of healthy behaviors and avoidance of alcohol, tobacco, and illicit drugs (ACOG, 2005; CDC, 2012; Shawe et al., 2015) . However, preconception health guidance varies and may not address parameters of pregnancy intention, gaps in preconception health knowledge, and specific preconception behaviors (Toivonen et al., 2017) . To date, research examining preconception substance use and unplanned pregnancy is limited, and often based on retrospective study methodology including assessment of substance use after pregnancy resolution, and often lacking appropriate control of confounders. Findings previously reported that women who binge drink or use illicit substances including marijuana engage in sexual behaviors that place them at increased risk for unplanned or poorly timed pregnancies including early sexual initiation, multiple sexual partners, inconsistent use of condoms or unprotected intercourse, and unintended intercourse while intoxicated or under the influence (Tapert et al., 2001; Brook et al., 2004; Baskin-Sommers and Sommers, 2006; van Gelder et al., 2011) . However, differences in study methodology including evaluation of pregnancy intention and preconception substance use among a nonpregnant population of women (Chuang et al., 2010; Chuang et al., 2011) , or postpartum assessment of preconception substance exposure among individuals with livebirths only (Naimi et al., 2003; Dott et al., 2010; Krans et al., 2013 ) may contribute to inconsistent findings. Therefore, the relationship between preconception substance use and poorly timed or unplanned pregnancy warrants further investigation.
To address this issue, we evaluated the association between preconception tobacco, alcohol, marijuana, opioid, and cocaine use with unplanned or poorly timed pregnancy among a cohort of pregnant women. Given the association of alcohol, tobacco, and illicit substances with high-risk sexual behavior, including lack of contraception use which can lead to unplanned and poorly timed pregnancies, we hypothesized that women with preconception substance use (tobacco, alcohol, marijuana, opioid, cocaine) would be more likely to have an unplanned or poorly timed pregnancies compared with women without substance use. By investigating this relationship, there may be an opportunity to identify women at risk for unplanned or poorly timed pregnancy and develop interventions focused on increasing contraception access and use, and optimizing healthy preconception behaviors.
METHODS

Study Cohort
We performed a secondary analysis of data from a prospective cohort study examining the association of major depressive episodes (MDEs) and/or antidepressant medication use in pregnancy with adverse birth outcomes (Yonkers et al., 2011; Yonkers et al., 2012) . Research staff recruited and enrolled pregnant women receiving prenatal care from 137 obstetric practices and hospital-based clinics in Connecticut and western Massachusetts between 2005 and 2009. Eligibility criteria included women 16 to 18 years and older (depending on enrollment site), less than 17 weeks estimated gestational age (EGA) at enrollment with a presumed singleton pregnancy, speaking English or Spanish, and having access to a telephone. Women were excluded if they were planning to terminate their pregnancy, intending to relocate, or had insulin dependent diabetes. The initial home interview was conducted before 18 weeks' EGA. Detailed study methods, including recruitment, enrollment, and assessment procedures, and research staff training have been reported previously (Yonkers et al., 2011; Yonkers et al., 2012) . Yale University Institutional Review Board provided human subjects approval for the original study.
Preconception Substance Use Assessment
At the initial interview, preconception substance use was ascertained, including: tobacco use in the 6 months before conception; and alcohol, marijuana, opioid (methadone and oxycontin), and cocaine use in the month before conception. Preconception tobacco use was categorized as: none, 1 to 9 cigarettes per day, 10 to 19 cigarettes per day, and 20þ cigarettes per day (Fergusson et al., 1998) . We evaluated preconception alcohol use using detailed information ascertained for beverage type, amount of consumption, and frequency of use during the month before conception. Alcohol exposure was categorized as: none, up to 1 drink per day, 1 to <2 drinks per day, 2 or more drinks per day, binge drinking (defined as 4 or more drinks per occasion), and ''heavy drinking.'' The category of ''heavy drinking'' was defined using National Institute of Alcohol Abuse and Alcoholism (NIAAA) criteria as: binge drinking (4 or more drinks per occasion for women) on 5 or more days during the past month (NIAAA). Levels of preconception alcohol use including binge drinking and heavy drinking were evaluated as mutually exclusive categories; therefore ''binge'' drinking only included women who did not meet the criteria of ''heavy drinking.'' Alcohol exposure categories were developed to provide distinction regarding level of exposure and specific behavior or patterns of exposure (eg, binge drinking). Marijuana use was defined as: none, 2 to 3 times per month, 1 to 6 times per week, and 1 to 4 times per day. Tobacco, alcohol, and marijuana assessment also included dichotomous measures of any exposure (yes/no). Opioid and cocaine use were defined as any reported use (yes/no) the month before pregnancy. While the interview included assessment of other illicit exposures including lysergic acid diethylamide (LSD), methamphetamines, and heroin, the number of participants reporting preconception exposure to these substances (<0.2% of study sample) was too few for statistical analysis.
Potential Confounding Variables
Sociodemographic and clinical data were obtained, including maternal age, race and ethnicity, level of education, relationship status, parity, medical history, and reproductive history. Psychiatric diagnoses within 6 months before pregnancy including MDE, minor depressive symptoms, posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), panic disorder, and sexual molestation or abuse before age 18 were also ascertained at the home interview and evaluated for this analysis, as substance use disorders are associated with psychiatric conditions (SAMSHA, 2016) and history of adolescent physical or sexual abuse (Kilpatrick et al., 2003) . MDE was evaluated using the World Mental Health Composite International Diagnostic Interview v2.1 (WMH-CIDI) (CIDI) module for depression (Wittchen, 1994) ; panic disorder and GAD were assessed using CIDI modules and PTSD determined through administration of the modified PTSD symptom scale (Falsetti et al., 1993) .
Statistical Analysis
Bivariate analyses of demographic variables and preconception substance use with dichotomized measures of pregnancy planning and timing were performed using chisquare or Fisher exact test, where appropriate. Potential confounders were evaluated by examining bivariate tests of association. Covariates meeting criteria of P < 0.15 for association with specific preconception substance use and outcome (planning/timing) under consideration were included in specific multivariable models accordingly as potential confounders. Unadjusted and multivariable logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for preconception substance use, and pregnancy planning and timing. Separate models were generated for individual preconception substance exposures with pregnancy planning and timing as independent dichotomous outcomes. Final models were developed using multivariable logistic regression including potential confounders. SAS 9.4 (SAS Institute, Cary, NC) was used for statistical analysis.
RESULTS
Among this cohort of 2654 women with singleton live births, 37.2% of participants reported unplanned pregnancies and 13.0% reported that it was not a good time to be pregnant; 39.0% reported either unplanned or poorly timed pregnancies (Table 1) . Most study participants were 30 years or older (59.7%), white or Caucasian (73.7%), married (71.2%), had mean household income of greater than $30,000 (83%), and at least a college degree (56.6%). GAD and MDE diagnosed at least 6 months before pregnancy were reported by 7.8% and 8.8% of the cohort, respectively. Pre-existing diagnosis of PTSD was reported by 10.5%, panic disorder reported by 4.5%, and history of sexual molestation before age 18 was reported by 16.7%. Participant characteristics demonstrated a significant association with pregnancy planning and timing (P < 0.05), with the exception of minor depressive symptoms in the 6 months before conception and pregnancy planning, and panic disorder in the 6 months before conception and pregnancy timing (Table 1) .
Overall, 20.2% smoked cigarettes at least 6 months before pregnancy, whereas in the month before pregnancy, 71.8% reported drinking alcohol (of which 4.0% reported binge drinking and 3.6% reported heavy drinking as defined by NIAAA), 6.5% reported using marijuana, and approximately 1% reported using opioids or cocaine (Table 2) . Unadjusted OR estimates demonstrate a dose-response effect of preconception cigarette smoking with pregnancy planning and timing, with increasing daily tobacco use associated with an increased risk of unplanned or poorly timed pregnancy. Risk estimates ranged from OR 2.10 (95% CI 1.46-3.02) among those smoking <10 cigarettes per day in the 6 months preconception and poorly timed pregnancy compared with nonsmokers, to OR 3.87 (95% CI 2.70-5.55) among women smoking 20þ cigarettes per day and poorly timed and/or unplanned pregnancy compared with nonsmokers. A curvilinear effect is observed for categories of increasing preconception alcohol exposure with unplanned, and unplanned and/ or poorly timed pregnancy; reduced risk estimates are observed for preconception alcohol exposure up to 2 drinks per day and increased risk estimates for binge drinking and heavy drinking compared with nondrinkers. Dichotomous measures of preconception smoking demonstrate an increased risk for unplanned or poorly timed pregnancy, whereas alcohol use demonstrates a reduced risk for these outcomes compared with no exposure. Preconception marijuana and opioid use was associated with an increased risk for poorly timed or unplanned pregnancies compared with no use, whereas cocaine use the month before pregnancy was associated with unplanned pregnancies, and unplanned and/or poorly timed pregnancies, compared with individuals who did not use cocaine.
After multivariable adjustment for potential confounding variables (Table 3 ; Supplemental Fig. 1 , http://links. lww.com/JAM/A82), binge drinking the month before pregnancy (excluding NIAAA-defined heavy drinking) was associated with increased odds of poorly timed, and also unplanned pregnancy (OR 1.75, 95% CI 1.01-3.05; and OR 1.68, 95% CI 1.01-2.79, respectively) compared with those who abstained from alcohol. Marijuana use 2 to 3 times in the month before pregnancy was associated with unplanned pregnancy (OR 1.78, 95% CI 1.03-3.08), and poorly timed and/or unplanned pregnancy (OR 1.79, 95% CI 1.01-3.17) compared with those who did not use marijuana. Similarly, any reported marijuana use compared with no use was associated with an increased risk of unplanned pregnancy (OR 1.60, 95% CI 1.05-2.43). Opioid use the month before conception was associated with a nearly 3-fold risk of poorly timed pregnancy (OR 2.87, 95% CI 1.03-7.99), compared with those not using opioids. Adjusted estimates for preconception cigarette smoking and cocaine use were not associated with pregnancy planning or timing. 
DISCUSSION
Our analysis of preconception substance use, and pregnancy timing and planning among a cohort of pregnant women demonstrated an increased odds for unplanned pregnancy, and also poorly timed pregnancy among women reporting preconception binge drinking (not including NIAAA-defined heavy drinking) and marijuana use the month before conception was associated with increased odds of unplanned as well as poorly timed and/or unplanned pregnancy. Additionally, preconception opioid use showed increased odds of poorly timed pregnancy compared with no use. Associations between smoking or cocaine use with pregnancy planning and timing were attenuated after performing multivariable modeling. By assessing preconception substance use and pregnancy planning and timing early in pregnancy, and performing multivariable adjustment for comprehensive confounding factors including maternal demographic, medical, reproductive, and psychiatric variables, our analysis extends and improves upon previous literature of preconception substance use among a general obstetrics population and measures of pregnancy perspectives, including pregnancy planning and timing.
Previous studies have reported a relationship between preconception alcohol and cigarette smoking with unintended pregnancies (Hellerstedt et al., 1998; Oulman et al., 2015) , yet studies are often limited by retrospective ascertainment of substance use and pregnancy context (including planning and timing), which may be prone to recall and social desirability bias. Earlier analysis of the Pregnancy Risk Assessment Monitoring System (PRAMS) data reported binge drinking before conception increased the likelihood of unintended pregnancy among White women but not Black women (Naimi et al., 2003) ; however, this retrospective assessment of substance use is also subject to potential bias. We found an increased risk of binge drinking (excluding NIAAA-defined heavy drinking) and poorly timed or unplanned pregnancy after adjusting for confounders including race and ethnicity. However, comparisons across studies are complicated by inherent differences in defined measures of intention, timing and planning; evaluation of unintended pregnancy in PRAMS data (Naimi et al., 2003) includes pregnancies defined as both unwanted and mistimed, hence may be subject to misclassification. Our outcome measures of poorly timed and unplanned were assessed as discrete response options among study participants, thus reflecting a direct response to the pregnancy perspective under consideration. Our study differed from previous studies that have reported preconception substance exposure to cigarette smoking increased the likelihood of unintended pregnancy (Hellerstedt et al., 1998; Than et al., 2005; Dott et al., 2010; Oulman et al., 2015) . While unadjusted estimates were elevated for preconception smoking and poorly timed or unplanned pregnancies in our study, controlling for potential confounders resulted in attenuated estimates, demonstrating the importance of robust multivariable analysis. Previous studies have also reported pregnant women abusing opioids have elevated rates of unintended pregnancies (Heil et al., 2011) ; while we did not specifically assess opioid use disorders or methadone maintenance, our data showed preconception opioid use was associated with poorly timed pregnancy, but not unplanned pregnancy, albeit exposure to opioids among our cohort was low. Overall, differences in our findings compared to previous studies may be due to variation in study methodology, assessment of substance and pregnancy perspectives, and lack of comprehensive multivariable adjustment for confounders.
This study extends the literature on the association between preconception substance use and unplanned or poorly timed pregnancy. Previous studies have ascertained pregnancy intention or planning, and also preconception alcohol, smoking and substance use after delivery, with information ascertainment ranging from the first 6 months postpartum (Naimi et al., 2003) , up to 24 months after delivery (Dott et al., 2010) , or up to 15 years postpartum (Than et al., 2005) . Compared with previous studies, we ascertained pregnancy planning, timing, and preconception substance use in early gestation (less than 18 weeks' EGA) and prospective to delivery, thus minimizing recall and social desirability bias compared with studies with assessments completed after birth outcome. However, future studies with preconception assessment of pregnancy perspectives including planning and timing would be particularly informative and further reduce potential bias. Similar to previous studies (Naimi et al., 2003; Dott et al., 2010; Krans et al., 2013; Oulman et al., 2015) , our cohort was restricted to pregnancies resulting in livebirth deliveries only, excluding the population of women with miscarriage or termination and therefore limiting generalizability to the population of pregnant women. In addition, individuals with miscarriage or termination may vary in preconception substance exposure compared with those delivering; further research regarding this population is warranted. Finally, we objectively defined and controlled for psychiatric and mental health disorders in the 6 months before conception, improving upon earlier studies that did not account for these potential confounders (Hellerstedt et al., 1998; Naimi et al., 2003; Than et al., 2005; Heil et al., 2011) . Psychiatric variables are important factors to consider in the analysis of pregnancy planning and timing, as studies have reported associations of mental health and substance use (SAMSHA, 2016) , and also psychiatric conditions and unplanned or unintended pregnancies (Takahashi et al., 2012; Hall et al., 2014; Gariepy et al., 2016) .
In the current analysis, we evaluated pregnancy planning and timing as separate pregnancy perspectives. Recent studies have noted the importance of extending patient-centered reproductive and pregnancy context measures, including further evaluation of traditional constructs of pregnancy planning and intention (Aiken et al., 2016; Mumford et al., 2016; Gariepy et al., 2017) . Our analysis considered pregnancy planning and timing both independently and collectively, based on discrete questions that elicited dichotomous responses for whether the pregnancy was planned or whether the pregnancy occurred at a good time (Gariepy et al., 2016) .
There are several study limitations that should be acknowledged. Our study sample comprised women from a general obstetric population delivering singleton, liveborn infants, and excluded pregnancy terminations and miscarriage, thus limiting generalizability of our findings to the general population with all pregnancy experiences. Further, the cohort was comprised of women who were primarily married, college graduates (16 years of school or more), Caucasian, and 30 years or older, and therefore may not reflect the general population of reproductive-aged women. While pregnancies resulting in termination or miscarriage were not included, overall 39% reported unplanned or poorly timed pregnancies, which is just slightly below national rates of unintended pregnancy (45%) (Finer and Zolna, 2016) . Our observed proportion of unplanned and/or poorly timed pregnancy may be influenced by the exclusion of terminations and miscarriage, and also sociodemographic characteristics of the study cohort. Future studies of pregnancy planning and timing including women who did not become pregnant and follow-up of pregnant women with all pregnancy outcomes would yield further insight regarding the risk of substance use.
Recruitment from this obstetrics population may not include women with substance use disorders, who may enter prenatal care later if it all, and may be seen by high-risk obstetric clinics offering specialized care. We did not assess chronic substance use or substance use disorders, which may represent unique risk behaviors, including infrequent use of effective contraception (Terplan et al., 2015) . Additionally, women with substance use may be more likely to have unplanned pregnancies leading to termination; however, this complex relationship warrants further evaluation (Martino et al., 2006) . Interviewing women at the time of pregnancy diagnosis would permit assessment of substance use, and also pregnancy planning and timing before pregnancy resolution, including women who have pregnancy terminations. For the current study, the initial interview was conducted in-person and interviewer-administered, hence may be subject to social desirability bias which could affect reporting of substance use and pregnancy planning and timing. However, research team members completed in-depth training in interview techniques, and periodic validity checks were employed during the study to ensure quality control.
Assessments of substance use during pregnancy may also be subject to potential underreporting (Garg et al., 2016) ; however, our questions regarding preconception substance use were administered early in pregnancy before delivery to minimize recall bias and close in temporality to the preconception period. Our study reports a greater proportion of preconception alcohol exposure than other studies of preconception substance use and pregnancy intention (Hellerstedt et al., 1998; Than et al., 2005) , which would not suggest underreporting. Further, prevalence of preconception substance use among the cohort is similar to previously reported preconception tobacco use (Krans et al., 2013) , and similar to median estimates of smoking among US reproductive-age women of 22.4% (CDC, 2008) . While preconception marijuana use in our study (6.5%) is lower than estimates from the National Survey of Family Growth (NSFG) of 13% among nonpregnant women aged 15 to 44 years (van Gelder et al., 2011) , it exceeds estimated rates of use during pregnancy ranging from 2% to 5% (ACOG, 2017) .
Among the current study sample, preconception substance exposure was not biologically confirmed using laboratory markers for substance use; however, such confirmation is often restricted to a limited window after exposure. Our cohort was also limited by having only a small percentage of women reporting preconception opioid (0.9%) and cocaine (0.9%) use, and opioid use could not be distinguished as prescribed or not prescribed. With an estimated one-fifth (20%) of reproductive-aged women on Medicaid receiving opioid prescriptions during 2008 to 2013 (Gallagher et al., 2016) , further evaluation of opioid and other substance exposures during the preconception period is warranted. Finally, few participants reported use of other illicit drugs including heroin, LSD, and methamphetamines, thus precluding analysis of these illicit substances and pregnancy planning and timing.
In summary, our study demonstrates preconception binge drinking, marijuana use, and opioid use was associated with an increased risk of unplanned pregnancy and poor pregnancy timing. While we did not observe an increased risk for unplanned or poorly timed pregnancies among women reporting tobacco or cocaine use prior to conception, the prevalence of preconception substance exposure among this cohort of reproductive aged women points to opportunities for targeted efforts to improve preconception health, provide treatment for individuals using substances, and optimize access and use of effective methods of contraception. Future public health interventions should also consider the complexity of the relationship between substance use, pregnancy planning and timing, and other variables including coexisting psychiatric conditions when addressing the needs of this population.
